Education
About Us
Working with TipRanks
Follow Us
Hester Biosciences Limited (IN:HESTERBIO)
:HESTERBIO
HESTERBIO Stock Chart & Stats
₹1648.95
-₹5.75(-0.24%)
At close: 4:00 PM EST
₹1648.95
-₹5.75(-0.24%)
Day’s Range― - ―
52-Week Range₹1,246.75 - ₹2,669.00
Previous CloseN/A
Volume2.45K
Average Volume (3M)308.00
Market Cap
₹14.09B
Enterprise Value₹18.29B
Total Cash (Recent Filing)₹72.19M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)32.1
Beta0.45
Next Earnings
Feb 14, 2026EPS EstimateN/A
Last Dividend Ex-Date
Aug 06, 2025Dividend Yield0.42%
Share Statistics
EPS (TTM)16.98
Shares Outstanding8,506,865
10 Day Avg. Volume428
30 Day Avg. Volume308
Financial Highlights & Ratios
PEG Ratio0.96
Price to Book (P/B)3.84
Price to Sales (P/S)3.88
P/FCF Ratio27.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Hester Biosciences Limited News
HESTERBIO FAQ
What was Hester Biosciences Limited’s price range in the past 12 months?
Hester Biosciences Limited lowest stock price was ₹1246.75 and its highest was ₹2669.00 in the past 12 months.
What is Hester Biosciences Limited’s market cap?
Hester Biosciences Limited’s market cap is ₹14.09B.
When is Hester Biosciences Limited’s upcoming earnings report date?
Hester Biosciences Limited’s upcoming earnings report date is Feb 14, 2026 which is in 75 days.
How were Hester Biosciences Limited’s earnings last quarter?
Hester Biosciences Limited released its earnings results on Nov 12, 2025. The company reported ₹16.985 earnings per share for the quarter, beating the consensus estimate of N/A by ₹16.985.
Is Hester Biosciences Limited overvalued?
According to Wall Street analysts Hester Biosciences Limited’s price is currently Overvalued.
Does Hester Biosciences Limited pay dividends?
Hester Biosciences Limited pays a Annually dividend of ₹7 which represents an annual dividend yield of 0.42%. See more information on Hester Biosciences Limited dividends here
What is Hester Biosciences Limited’s EPS estimate?
Hester Biosciences Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hester Biosciences Limited have?
Hester Biosciences Limited has 8,506,865 shares outstanding.
What happened to Hester Biosciences Limited’s price movement after its last earnings report?
Hester Biosciences Limited reported an EPS of ₹16.985 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 3.102%.
Which hedge fund is a major shareholder of Hester Biosciences Limited?
Currently, no hedge funds are holding shares in IN:HESTERBIO
Company Description
Hester Biosciences Limited
Hester Biosciences Limited (HESTERBIO) is a leading biotechnology company based in India, specializing in the development and manufacturing of veterinary vaccines and biological products. Established in 1987, Hester focuses on providing innovative solutions for animal health, primarily in the poultry and livestock sectors. The company offers a diverse range of products, including vaccines, diagnostics, and health products, aimed at improving the health and productivity of animals.
Technical Analysis
Gufic Biosciences Limited
―
Indoco Remedies Limited
―
Morepen Laboratories Limited
―
Sequent Scientific Limited
―
Unichem Laboratories Limited
―